CAR-T therapy shows early signals in multiple sclerosis as serious neurotoxicity and a death are disclosed
In an early trial involving 66 participants, disease activity and disability remained stable in some patients, but serious neurotoxicity and a fatal infection also mean that the potential benefits of a single cell infusion must be weighed against the risks of the overall treatment.